Ursprung des Netzwerks ersten Grades von Ichiro Kitasato
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Generic | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ichiro Kitasato
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| SUMITOMO CHEMICAL CO., LTD. | Chemicals: Specialty | Corporate Officer/Principal | |
| TOWA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| MORISHITA JINTAN CO., LTD. | Pharmaceuticals: Other | President | |
| George Washington University | College/University | Undergraduate Degree | |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Leeds | College/University | Doctorate Degree | |
| KOLON TISSUEGENE, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| The Johns Hopkins University | College/University | Graduate Degree | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
| Fudan University | College/University | Undergraduate Degree | |
| SOLASIA PHARMA K.K. | Pharmaceuticals: Major | Director/Board Member | |
IMMD, Inc.
 IMMD, Inc. BiotechnologyHealth Technology IMMD, Inc. provides drug discovery research for pharmaceutical companies. It identifies drug seeds by virtual screening, to select promising seeds and to optimize the seeds by minimum syntheses, based on estimated docking mode to the target. The firm also establishes a drug discovery method using software system for rational drug design based on 3-D structures of target proteins. Its business activities also include collaborative drug discovery researches, in-house drug discovery program, and drug seeds. The company was founded by Akiko Itai on March 16, 1995 and is headquartered in Tokyo, Japan. | Biotechnology | Corporate Officer/Principal | |
RRD International LLC
 RRD International LLC Miscellaneous Commercial ServicesCommercial Services RRD International LLC develops biopharmaceutical products. The firm offers product development support to biotechnology, pharmaceutical and medical device companies. Its services include development, strategic planning, program management and research. The company was founded by Frank L. Hurley and Charles W. Finn in 2002 and is headquartered in Rockville, MD. | Miscellaneous Commercial Services | General Counsel | |
| AnGes Euro Ltd. | Director/Board Member | ||
Bristol-Myers Squibb KK
 Bristol-Myers Squibb KK BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb KK develops, manufactures and markets biopharmaceutical products. The company is based in Shinjuku-ku, Japan. | Biotechnology | Director/Board Member | |
AnGes USA, Inc.
 AnGes USA, Inc. Pharmaceuticals: MajorHealth Technology Part of AnGes, Inc., AnGes USA, Inc. develops and manufactures medicines. The company is based in Gaithersburg, MD. Ei Yamada has been the CEO of the company since 2014. | Pharmaceuticals: Major | Chief Executive Officer | |
GenomIdea, Inc.
 GenomIdea, Inc. BiotechnologyHealth Technology Part of ISHIHARA SANGYO KAISHA LTD., GenomIdea, Inc. engages in biopharmaceutical products development and distribution. The company is based in Ibaraki, Japan. GenomIdea was acquired by ISHIHARA SANGYO KAISHA LTD. from AnGes, Inc. on January 31, 2013 for $0.0 million. | Biotechnology | Director/Board Member | |
| Quality Biotech, Inc. | Corporate Officer/Principal | ||
| FUNPEP COMPANY LIMITED | Biotechnology | Director/Board Member | |
Oriciro Genomics, Inc.
 Oriciro Genomics, Inc. BiotechnologyHealth Technology Oriciro Genomics, Inc. develops DNA based assembly and amplification technology solutions. The company was founded in December 2018 and is headquartered in Tokyo, Japan. | Biotechnology | Chief Executive Officer | |
| Point Market KK | Director/Board Member | ||
| SIRNAOMICS LTD. | Biotechnology | Corporate Officer/Principal | |
| Personal Diagnostix, Inc. | Chief Executive Officer | ||
| KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member |
Statistik
International
| Japan | 13 |
| Vereinigte Staaten | 10 |
| Vereinigtes Königreich | 3 |
| China | 2 |
| Hong Kong | 2 |
Sektoral
| Health Technology | 15 |
| Consumer Services | 5 |
| Commercial Services | 3 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 16 |
| Corporate Officer/Principal | 11 |
| Independent Dir/Board Member | 7 |
| General Counsel | 5 |
| Comptroller/Controller/Auditor | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Zhi Feng Long | 7 |
| Shunsuke Sami | 6 |
| Diana Halim | 6 |
| Norikazu Eiki | 5 |
| Makoto Hara | 3 |
| Junichi Komamura | 3 |
| Seiji Hirasaki | 3 |
| Noriaki Ohmura | 1 |
| Tetsuji Yoneo | 1 |
- Börse
- Insiders
- Ichiro Kitasato
- Unternehmensverbindungen
